-
1.发明授权ORAL FORMULATION WITH BENEFICIAL CARDIOVASCULAR EFFECTS, COMPRISING BERBERINE 有权以良好的心血管效应及其内容黄连素口服制剂
公开(公告)号：EP2007429B1
公开(公告)日：2012-02-29
申请号：EP07735308.4
申请日：2007-03-29
Applicant: ROTTAPHARM S.P.A.
Inventor： SENIN, Paolo , SETNIKAR, Ivo , ROVATI, Luigi Angelo
IPC: A61K31/045 , A61K31/122 , A61K31/4741 , A61K31/519 , A61K36/29 , A61K36/06 , A61K36/05 , A61K45/06
CPC classification number: A61K45/06 , A61K31/045 , A61K31/122 , A61K31/4741 , A61K31/519 , A61K36/05 , A61K36/06 , A61K36/29 , A61K2300/00
Abstract: Formulation for oral administration, in the form of tablets or of powder for extemporaneous use, able to exert a beneficial effect on the cardiovascular system and having eulipidaemic activity, cholesterol-lowering and triglyceride-lowering activity, antioxidant activity, and a protective action on the vasal endothelium, comprising berberine in combination with a policosanol and/or red yeast and preferably containing an antioxidant, such as astaxanthin and/or folic acid.
-
2.发明公开
公开(公告)号：EP1827136A1
公开(公告)日：2007-09-05
申请号：EP05792107.4
申请日：2005-09-20
Applicant: ROTTAPHARM S.P.A.
Inventor： SENIN, Paolo , SETNIKAR, Ivo , ROVATI, Luigi, Angelo
IPC: A23L1/30
CPC classification number: A61K31/125 , A23L17/60 , A23L33/105 , A23L33/14 , A23L33/15 , A23V2002/00 , A61K31/045 , A61K31/122 , A61K31/505 , A61K36/05 , A61K36/062 , C09B67/0097 , A61K2300/00 , A23V2200/326 , A23V2250/314 , A23V2250/218 , A23V2250/202 , A23V2250/7056
Abstract: Composition for oral administration, having a health- promoting effect on the cardiovascular system, comprising as active principles a policosanol or a mixture of policosanols, red yeast and an agent selected from astaxanthin and folic acid, preferably in combination with coenzyme Q10. The composition can be used in particular for the preparation of food supplements having health-promoting effects, such as eulipidaemic effect, correction of homocysteinaemia, antioxidant action and a protective effect on the vasal endothelium.
-
3.发明公开ORAL FORMULATION WITH BENEFICIAL CARDIOVASCULAR EFFECTS, COMPRISING BERBERINE 有权以良好的心血管效应及其内容黄连素口服制剂
公开(公告)号：EP2007429A1
公开(公告)日：2008-12-31
申请号：EP07735308.4
申请日：2007-03-29
Applicant: ROTTAPHARM S.P.A.
Inventor： SENIN, Paolo , SETNIKAR, Ivo , ROVATI, Luigi Angelo
IPC: A61K45/06 , A61P9/00 , A61K31/122 , A61K31/519 , A61K31/4745 , A61K36/06 , A61K36/29 , A61K36/05
CPC classification number: A61K45/06 , A61K31/045 , A61K31/122 , A61K31/4741 , A61K31/519 , A61K36/05 , A61K36/06 , A61K36/29 , A61K2300/00
Abstract: Formulation for oral administration, in the form of tablets or of powder for extemporaneous use, able to exert a beneficial effect on the cardiovascular system and having eulipidaemic activity, cholesterol-lowering and triglyceride-lowering activity, antioxidant activity, and a protective action on the vasal endothelium, comprising berberine in combination with a policosanol and/or red yeast and preferably containing an antioxidant, such as astaxanthin and/or folic acid.
-
4.发明授权
公开(公告)号：EP1827136B1
公开(公告)日：2008-06-04
申请号：EP05792107.4
申请日：2005-09-20
Applicant: ROTTAPHARM S.P.A.
Inventor： SENIN, Paolo , SETNIKAR, Ivo , ROVATI, Luigi, Angelo
IPC: A23L1/30
CPC classification number: A61K31/125 , A23L17/60 , A23L33/105 , A23L33/14 , A23L33/15 , A23V2002/00 , A61K31/045 , A61K31/122 , A61K31/505 , A61K36/05 , A61K36/062 , C09B67/0097 , A61K2300/00 , A23V2200/326 , A23V2250/314 , A23V2250/218 , A23V2250/202 , A23V2250/7056
Abstract: Composition for oral administration, having a health- promoting effect on the cardiovascular system, comprising as active principles a policosanol or a mixture of policosanols, red yeast and an agent selected from astaxanthin and folic acid, preferably in combination with coenzyme Q10. The composition can be used in particular for the preparation of food supplements having health-promoting effects, such as eulipidaemic effect, correction of homocysteinaemia, antioxidant action and a protective effect on the vasal endothelium.
-
-
-
Search Results
4
records
(took 0.011 seconds)
